References
Arulkanthan, A., W.C. Brown, T.C. McGuire, and D.P. Knowles, 1999:
Biased immunoglobulin G1 isotype responses induced in cattle with DNA
expressing msp1a of Anaplasma marginale. Infect. Immun.67 , 3481–7.
Babiuk, L.A., J. L’Italien, S. van Drunen Littel-van den Hurk, T. Zamb,
M.J.P. Lawman, G. Hughes, and G.A. Gifford, 1987: Protection of cattle
from bovine herpesvirus type I (BHV-1) infection by immunization with
individual viral glycoproteins. Virology 159 , 57–66,
DOI: 10.1016/0042-6822(87)90347-3.
Banchereau, J., F. Bazan, D. Blanchard, F. Briè, J.P. Galizzi, C. van
Kooten, Y.J. Liu, F. Rousset, and S. Saeland, 1994: The CD40 Antigen and
its Ligand Vol. 12Annu. Rev. Immunol.
Bao, Y., X. Liu, C. Han, S. Xu, B. Xie, Q. Zhang, Y. Gu, J. Hou, L.
Qian, C. Qian, H. Han, and X. Cao, 2014: Identification of
IFN-γ-producing innate B cells. Cell Res. 24 , 161–76,
DOI: 10.1038/cr.2013.155.
Bitsch, V., 1973: Infectious bovine rhinotracheitis virus infection in
bulls, with special reference to preputial infection. Appl.
Microbiol. 26 , 337–43.
Blickenstorfer, S., M. Engels, C. Guerdat, C. Saucy, M. Reist, H.
Schwermer, and L. Perler, 2010: [Infectious bovine rhinotracheitis
(IBR) in the canton of Jura: an epidemiological outbreak
investigation]. Schweiz. Arch. Tierheilkd. 152 ,
555–60, DOI: 10.1024/0036-7281/a000124.
Blome, S., C. Gabriel, and M. Beer, 2013: [Possibilities and
limitations in veterinary vaccine development using the example of
classical swine fever]. Berl. Munch. Tierarztl. Wochenschr.126 , 481–490, DOI: 10.2376/0005-9366-126-41.
Brown, W.C., C.E. Suarez, L.K.M. Shoda, and D.. Estes, 1999: Modulation
of host immune responses by protozoal DNA. Vet. Immunol.
Immunopathol. 72 , 87–94, DOI: 10.1016/S0165-2427(99)00120-8.
Coutelier, J.P., J.T. van der Logt, and F.W. Heessen, 1991: IgG subclass
distribution of primary and secondary immune responses concomitant with
viral infection. J. Immunol. 147 , 1383–6.
Deshpande, M.S., T.C. Ambagala, N.R. Hegde, M.J. Hariharan, M.
Navaratnam, and S. Srikumaran, 2002: Induction of cytotoxic
T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization.Vaccine 20 , 3744–51, DOI:
10.1016/s0264-410x(02)00375-4.
Di Giacomo, S., V. Quattrocchi, and P. Zamorano, 2015: Use of Adjuvants
to Enhance the Immune Response Induced by a DNA Vaccine Against Bovine
Herpesvirus-1. Viral Immunol. 28 , 343–346, DOI:
10.1089/vim.2014.0113.
Elgueta, R., M.J. Benson, V.C. De Vries, A. Wasiuk, Y. Guo, and R.J.
Noelle, 2009 ( May): Molecular mechanism and function of CD40/CD40L
engagement in the immune system. Immunol. Rev. 229 ,
152–172, DOI: 10.1111/j.1600-065X.2009.00782.x. NIH Public Access.
Estes, D.M., and W.C. Brown, 2002 ( November): Type 1 and type 2
responses in regulation of Ig isotype expression in cattle. Vet.
Immunol. Immunopathol. 90 , 1–10, DOI:
10.1016/S0165-2427(02)00201-5.
Estes, D.M., A. Hirano, V.T. Heussler, D.A. Dobbelaere, and W.C. Brown,
1995: Expression and biological activities of bovine interleukin 4:
effects of recombinant bovine interleukin 4 on T cell proliferation and
B cell differentiation and proliferation in vitro. Cell. Immunol.163 , 268–79, DOI: 10.1006/cimm.1995.1126.
Feinberg, H., R. Castelli, K. Drickamer, P.H. Seeberger, and W.I. Weis,
2007: Multiple modes of binding enhance the affinity of DC-SIGN for high
mannose N-linked glycans found on viral glycoproteins. J. Biol.
Chem. 282 , 4202–4209, DOI: 10.1074/jbc.M609689200.
Fredriksen, B.N., and J. Grip, 2012: PLGA/PLA micro- and nanoparticle
formulations serve as antigen depots and induce elevated humoral
responses after immunization of Atlantic salmon (Salmo salar L.).Vaccine 30 , 656–67, DOI: 10.1016/j.vaccine.2011.10.105.
Fuller, A.O., and W.C. Lee, 1992: Herpes simplex virus type 1 entry
through a cascade of virus-cell interactions requires different roles of
gD and gH in penetration. J. Virol. 66 , 5002–5012, DOI:
10.1128/jvi.66.8.5002-5012.1992.
Gregoriadis, G., A. Bacon, W. Caparros-Wanderley, and B. McCormack, 2002
(20. December): A role for liposomes in genetic vaccination.Vaccine 20 , B1–B9, DOI: 10.1016/S0264-410X(02)00514-5.
Elsevier BV.
Hope, J.C., C.J. Howard, H. Prentice, and B. Charleston, 2006: Isolation
and purification of afferent lymph dendritic cells that drain the skin
of cattle. Nat. Protoc. 1 , 982–7, DOI:
10.1038/nprot.2006.125.
Huang, Y., L.A. Babiuk, and S. van Drunen Littel-van den Hurk, 2005:
Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine
induces cytotoxic T-lymphocyte responses in mice and cattle. J.
Gen. Virol. 86 , 887–898, DOI: 10.1099/vir.0.80533-0.
Ip, W.-K., and Y.-L. Lau, 2004: Distinct Maturation of, but Not
Migration between, Human Monocyte-Derived Dendritic Cells upon Ingestion
of Apoptotic Cells of Early or Late Phases. J. Immunol.173 , 189–196, DOI: 10.4049/jimmunol.173.1.189.
Jones, C., 2003 ( January): Herpes simplex virus type 1 and bovine
herpesvirus 1 latency. Clin. Microbiol. Rev. 16 , 79–95,
DOI: 10.1128/CMR.16.1.79-95.2003. Clin Microbiol Rev.
Kanthesh, M., N. Loide, N. Raghu, T.S. Gopenath, G.K. Chandrashekrappa,
K. Murugesan, G. Ashok, and K. Gobianand, 2018: DNA Vaccines.Medwin Publ. 3 .
Kawai, T., and S. Akira, 2007 (1. November): Signaling to NF-κB by
Toll-like receptors. Trends Mol. Med. 13 , 460–469, DOI:
10.1016/j.molmed.2007.09.002. Elsevier.
Krieg, A.M., A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R.
Teasdale, G.A. Koretzky, and D.M. Klinman, 1995: CpG motifs in bacterial
DNA trigger direct B-cell activation. Nature 374 ,
546–9, DOI: 10.1038/374546a0.
Kuwajima, S., T. Sato, K. Ishida, H. Tada, H. Tezuka, and T. Ohteki,
2006: Interleukin 15-dependent crosstalk between conventional and
plasmacytoid dendritic cells is essential for CpG-induced immune
activation. Nat. Immunol. 7 , 740–6, DOI:
10.1038/ni1348.
Langellotti, C.A., J.S. Pappalardo, V. Quattrocchi, C. Mongini, and P.
Zamorano, 2011: Induction of specific cytotoxic activity for bovine
herpesvirus-1 by DNA immunization with different adjuvants.Antiviral Res. 90 , 134–42, DOI:
10.1016/j.antiviral.2011.03.185.
Lee, S.H., S.N. Danishmalik, and J.I. Sin, 2015: DNA vaccines,
electroporation and their applications in cancer treatment. Hum.
Vaccines Immunother. 11 , 1889–1900, DOI:
10.1080/21645515.2015.1035502.
Lewis, P.J., van Drunen Littel-van den Hurk, and L.A. Babiuk, 1999:
Altering the cellular location of an antigen expressed by a DNA-based
vaccine modulates the immune response. J. Virol. 73 ,
10214–23.
Ludewig, B., F. Barchiesi, M. Pericin, R.M. Zinkernagel, H. Hengartner,
and R.A. Schwendener, 2000: In vivo antigen loading and activation of
dendritic cells via a liposomal peptide vaccine mediates protective
antiviral and anti-tumour immunity. Vaccine 19 , 23–32,
DOI: 10.1016/S0264-410X(00)00163-8.
Manoj, S., P.J. Griebel, L.A. Babiuk, and S. van Drunen Littel-van den
Hurk, 2004: Modulation of immune responses to bovine herpesvirus-1 in
cattle by immunization with a DNA vaccine encoding glycoprotein D as a
fusion protein with bovine CD154. Immunology 112 ,
328–38, DOI: 10.1111/j.1365-2567.2004.01877.x.
Mars, M.H., M.C.M. De Jong, P. Franken, and J.T. Van Oirschot, 2001:
Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine
in cattle in the field. Vaccine 19 , 1924–1930, DOI:
10.1016/S0264-410X(00)00435-7.
Miethke, A., G.M. Keil, F. Weiland, and T.C. Mettenleiter, 1995:
Unidirectional complementation between glycoprotein B homologues of
pseudorabies virus and bovine herpesvirus 1 is determined by the
carboxy-terminal part of the molecule. J. Gen. Virol. 76
( Pt 7) , 1623–35, DOI: 10.1099/0022-1317-76-7-1623.
Pappalardo, J.S., M.M. Chodilef, A.C. Mignaqui, R. Marcellino, A.L.
Zamit, S. Salmaso, T.S. Levchenko, V.P. Torchilin, and C.A. Robles,
2016: Novel mannose-α(1→2)-mannose decorated liposomes for dendritic
cell targeted nanovaccines: strong humoral and cell immune response
against Brucella ovis. p. 33. In: Int. Congr. Immunol. Vol. 46,
Suppl. 1 Aust. Melbourne: European Journal of Immunology.
Pappalardo, J.S., M. Toniutti, S. Salmaso, T.S. Levchenko, and V.P.
Torchilin, 2013: Compounds and methods for targeted immune system
delivery (Granted: 2018.05.08) United States Patent and Trademark Office
(USPTO), ed. World Intellectual Property Organization (WIPO). United
States of America.
Quattrocchi, V., I. Soria, C.A. Langellotti, V. Gnazzo, M. Gammella,
D.P. Moore, and P.I. Zamorano, 2017: A DNA vaccine formulated with
chemical adjuvant provides partial protection against bovine herpes
virus infection in cattle. Front. Immunol. 8 , DOI:
10.3389/fimmu.2017.00037.
Rajčáni, J., T. Moško, and I. Režuchová, 2005: Current developments in
viral DNA vaccines: shall they solve the unsolved? Rev. Med.
Virol. 15 , 303–325, DOI: 10.1002/rmv.467.
Raz, E., H. Tighe, Y. Sato, M. Corr, J.A. Dudler, M. Roman, S.L. Swain,
H.L. Spiegelberg, and D.A. Carson, 1996: Preferential induction of a Th1
immune response and inhibition of specific IgE antibody formation by
plasmid DNA immunization. Proc. Natl. Acad. Sci. U. S. A.93 , 5141–5145, DOI: 10.1073/pnas.93.10.5141.
Reed, L.J., and H. Muench, 1938: A simple method of estimating fifity
percent endpoints. Am. J. Epidemiol. 27 , 493–497, DOI:
10.1093/oxfordjournals.aje.a118408.
Robles, C., 2009: Protocolo para la obtención del antígeno HS (Hot
Saline Extract) de Brucella Ovis Cepa Reo 198 para el diagnóstico
serológico de la brucelosis ovina. Comunicación Técnica EEA Bariloche
Nro. 557. 2009., Bariloche.
Romera, S.A., L.A. Hilgers, M. Puntel, P.I. Zamorano, V.L. Alcon, M.J.
Dus Santos, J. Blanco Viera, M. V Borca, and A.M. Sadir, 2000: Adjuvant
effects of sulfolipo-cyclodextrin in a squalane-in-water and
water-in-mineral oil emulsions for BHV-1 vaccines in cattle.Vaccine 19 , 132–41, DOI: 10.1016/s0264-410x(00)00104-3.
Romera, S.A., M. Puntel, V. Quattrocchi, P.D.M. Zajac, P. Zamorano, J.
Blanco Viera, C. Carrillo, S. Chowdhury, M. V. Borca, and A.M. Sadir,
2014: Protection induced by a glycoprotein E-deleted bovine herpesvirus
type 1 marker strain used either as an inactivated or live attenuated
vaccine in cattle. BMC Vet. Res. 10 , 8, DOI:
10.1186/1746-6148-10-8.
Sin, J.I., J.J. Kim, R.L. Arnold, K.E. Shroff, D. McCallus, C. Pachuk,
S.P. McElhiney, M.W. Wolf, S.J. Pompa-de Bruin, T.J. Higgins, R.B.
Ciccarelli, and D.B. Weiner, 1999: IL-12 gene as a DNA vaccine adjuvant
in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated
protective immunity against herpes simplex virus-2 challenge. J.
Immunol. 162 , 2912–21.
Suschak, J.J., J.A. Williams, and C.S. Schmaljohn, 2017 (2. December):
Advancements in DNA vaccine vectors, non-mechanical delivery methods,
and molecular adjuvants to increase immunogenicity. Hum. Vaccines
Immunother. 13 , 2837–2848, DOI:
10.1080/21645515.2017.1330236. Taylor and Francis Inc.
Tikoo, S.K., M. Campos, and L.A. Babiuk, 1995: Bovine herpesvirus 1
(Bhv-1): Biology, Pathogenesis, and Control. Adv. Virus Res.45 , 191–223, DOI: 10.1016/S0065-3527(08)60061-5.
Van Drunen Littel-van den Hurk, R.P. Braun, P.J. Lewis, B.C. Karvonen,
M.E. Baca-Estrada, M. Snider, D. McCartney, T. Watts, and L.A. Babiuk,
1998: Intradermal immunization with a bovine herpesvirus-1 DNA vaccine
induces protective immunity in cattle. J. Gen. Virol. 79
( Pt 4) , 831–9, DOI: 10.1099/0022-1317-79-4-831.
van Drunen Littel-van den Hurk, S., 2006: Rationale and perspectives on
the success of vaccination against bovine herpesvirus-1. Vet.
Microbiol. 113 , 275–82, DOI: 10.1016/j.vetmic.2005.11.002.
Vázquez, M.B., M. Sureda, and J. Rebollo, 2012 (1. January): Dendritic
cells I: Basic biology and functions. Inmunologia 31 ,
21–30, DOI: 10.1016/j.inmuno.2011.10.001. Elsevier Doyma.
Yamakawa, Y., C. Pennelegion, S. Willcocks, A. Stalker, N. MacHugh, D.
Burt, T.J. Coffey, and D. Werling, 2008: Identification and functional
characterization of a bovine orthologue to DC-SIGN. J. Leukoc.
Biol. 83 , 1396–1403, DOI: 10.1189/jlb.0807523.
Yamamoto, S., T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T.
Tokunaga, 1992: Unique palindromic sequences in synthetic
oligonucleotides are required to induce IFN [correction of INF] and
augment IFN-mediated [correction of INF] natural killer activity.J. Immunol. 148 , 4072–6.
Zaman, M., M.F. Good, and I. Toth, 2013: Nanovaccines and their mode of
action. Methods 60 , 226–31, DOI:
10.1016/j.ymeth.2013.04.014.
Zamorano, P., O. Taboga, M. Domínguez, S.A. Romera, M. Puntel, C. Tami,
C. Mongini, C. Waldner, E. Palma, and A. Sadir, 2002: BHV-1 DNA
vaccination: Effect of the adjuvant RN-205 on the modulation of the
immune response in mice. Vaccine 20 , 2656–2664, DOI:
10.1016/S0264-410X(02)00211-6.
Zonouzi, A.A., A.P. Zonouzi, and M. Abkar, 2016: Recent Applications of
DNA Vaccines in Cancer Therapy Vol. 2016Mol. Med. J. Kashan,
Iran.